Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
JPB Foundation (n/a)
National Institute of Neurological Disorders and Stroke (NS38377, NS38377, NS097049)
National Institute on Aging (AG059686, AG059686)
National Institute of General Medical Sciences (T32GM007753)
Adrienne Helis Malvin Medical Research Foundation (M-2014)
Diana Helis Henry Medical Research Foundation (H-1, H-1)
- License Information
-
More Information
Article History
Received: 27 November 2019
Accepted: 13 February 2020
First Online: 13 March 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: TMD is a consultant for Mitokinin and owns stock options in the company. TMD and VLD are founders of Valted, LLC and holds an ownership equity interest in the company. TMD and VLD are founders and hold shares of stock options as well as equity in, Neuraly, Inc. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
